All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found 2 translations.
| Name | Current message text |
|---|---|
| h English (en) | Cancer treatment with certain chemotherapy drugs and/or radiation therapy may cause therapy-related AML (t-AML) or therapy-related MDS (t-MDS). The risk of these therapy-related myeloid diseases depends on the total dose of the chemotherapy drugs used and the radiation dose and treatment field. Some patients also have an inherited risk for t-AML and t-MDS. These therapy-related diseases usually occur within 7 years after treatment, but are rare in children. |
| h Chinese (zh) | 使用某些化学治疗药物和/或放射疗法进行癌症治疗可能会导致治疗相关的AML（t-AML）或治疗相关的MDS（t-MDS）。 这些与治疗有关的骨髓疾病的风险取决于所用化疗药物的总剂量以及放射剂量和治疗领域。 一些患者也有遗传性的t-AML和t-MDS风险。 这些与治疗有关的疾病通常在治疗后7年内发生，但在儿童中很少见。 |
